Deadline: 20-Jun-2026
The C-CAMP Wadhwani Innovation Network Centre of Excellence is inviting applications from Indian start-ups and academic innovators working on biotech and bioengineering solutions with commercial potential. The programme supports innovations beyond TRL4, including prototype refinement, pilot studies, validation studies, and scaling activities, with grants of up to ₹1 crore. Focus areas include healthcare, drugs, medical devices, diagnostics, industrial biotechnology, and agriculture.
Overview
The C-CAMP Wadhwani Innovation Network Centre of Excellence is supporting Indian start-ups and researchers to advance biotech and bioengineering innovations from the lab to market-ready solutions.
The initiative is designed to help academic and entrepreneurial research move beyond early-stage development and become scalable, industry-ready products or processes.
The programme aims to promote innovation, job creation, commercialization, and economic growth in India’s biotechnology and bioengineering ecosystem.
Key Focus Areas
The initiative focuses on Medical Devices and MedTech, Drug Discovery, Diagnostics, Agriculture, Industrial Biotechnology, Healthcare, Drugs, technology-driven products, intellectual property-based innovations, prototype refinement, pilot studies, validation studies, scale-up support, and commercialization of biotech and bioengineering solutions.
What the Centre Supports
The Centre provides financial assistance for technologies and innovations that are ready to move closer to commercialization.
Support may be provided for:
- Projects beyond TRL4
- Pilot studies
- Validation studies
- Prototype refinement
- Scaling-up innovations
- Generating additional data
- Performing validation required for next-level funding
- Developing technology-based products or processes
- Advancing intellectual property-driven innovations
- Preparing innovations for market entry
The programme is suitable for applicants who already have a promising technology and need support to move it toward industry readiness.
What Does TRL4 Mean?
TRL stands for Technology Readiness Level. It is a scale used to measure how mature a technology is.
A project beyond TRL4 has usually moved past basic research and early laboratory validation. This means the innovation should already have some proof of concept and should be ready for further validation, prototype improvement, pilot testing, or scale-up.
The programme is not intended for very early-stage ideas with no technical validation. It is designed for technologies that are ready to move from research toward commercialization.
Funding Amount
Selected applicants may receive grants of up to ₹1 crore.
The funding can support activities that help move innovations closer to market readiness, including pilot testing, validation, prototype refinement, and data generation for future investment or funding.
Who Is Eligible?
Eligible applicants include:
- Indian start-ups
- Academic innovators in India
- Researchers working on translation-based technologies
- Innovators developing commercially relevant biotech or bioengineering solutions
- Applicants working on technology-driven products or processes
- Applicants with innovations based on intellectual property or potential intellectual property
The innovation should have clear commercial potential and should be relevant to one or more of the programme’s priority sectors.
Eligible Technology Areas
Applicants may work in areas such as:
- Healthcare
- Drugs
- Medical devices
- MedTech
- Diagnostics
- Industrial biotechnology
- Agriculture
- Bioengineering
- Technology-based products
- Technology-based processes
The innovation should be product-oriented and capable of moving toward market adoption.
Why It Matters
Biotech and bioengineering innovations often require strong support between the research stage and market entry.
Many promising technologies fail to scale because they lack funding for validation, prototype refinement, market testing, or additional data generation. This programme helps bridge that gap.
By supporting Indian start-ups and academic innovators, the Centre helps convert research into practical solutions that can address unmet needs, create jobs, attract future funding, and contribute to economic growth.
Selection Criteria
Applications will be assessed based on the strength, relevance, and commercial potential of the proposed technology.
Key selection criteria include:
- Product-oriented technology
- Novelty of the innovation
- Potential for intellectual property generation
- Ability to address an unmet need
- Competent technical team
- Competent business team
- Clear business model
- Strong commercialization strategy
- Understanding of the end-user
- Understanding of market size
- Potential for scale-up
- Readiness for next-level funding or investment
Applicants should clearly explain both the technical value and the business potential of their innovation.
How to Apply
Applicants should prepare a strong application that explains the innovation, its current stage of development, commercial potential, and plan for market readiness.
Step 1: Confirm Technology Readiness
Applicants should ensure that their innovation is beyond TRL4.
The technology should have moved beyond basic research and should be ready for pilot testing, validation, prototype refinement, or scaling support.
Step 2: Define the Innovation Clearly
The application should explain what the product, process, or technology does.
Applicants should describe:
- The problem being solved
- The unmet need being addressed
- The proposed solution
- The technology behind the innovation
- The current development stage
- The expected impact on users or markets
Step 3: Explain the Commercial Potential
Applicants should show how the innovation can become a market-ready product or process.
This section should include:
- Target users
- Market size
- Business model
- Commercialization pathway
- Revenue potential
- Competitive advantage
- Industry relevance
Step 4: Describe the Technical and Business Team
The application should demonstrate that the team has the skills required to develop, validate, and commercialize the innovation.
Applicants should highlight:
- Technical expertise
- Business experience
- Product development capacity
- Research or industry background
- Ability to execute the proposed project
Step 5: Present the Validation or Scale-Up Plan
Applicants should explain how the grant will help advance the innovation.
The plan may include:
- Pilot studies
- Validation studies
- Prototype refinement
- Scale-up activities
- Additional data generation
- Market-readiness activities
- Preparation for next-level funding
Step 6: Prepare the Budget
Applicants should prepare a realistic budget of up to ₹1 crore.
The budget should clearly link the requested funding to project activities such as validation, prototype improvement, testing, or scaling.
Step 7: Submit the Application
Applicants should submit the completed application with all required project, technical, business, and financial information through the official application process.
Tips for a Strong Application
A strong application should show that the innovation is technically sound, commercially relevant, and ready for translation.
Applicants should:
- Clearly explain the unmet need
- Show why the technology is novel
- Demonstrate product-market relevance
- Highlight potential for intellectual property
- Present a clear commercialization strategy
- Provide evidence of technical validation
- Explain how the grant will move the innovation forward
- Show a strong technical and business team
- Define the target user and market size
- Present a practical plan for pilot testing, validation, or scale-up
Common Mistakes to Avoid
Applicants should avoid submitting proposals that are too early-stage or unclear in commercial direction.
Common mistakes include:
- Applying with an idea that is not beyond TRL4
- Not explaining the product or process clearly
- Weak description of the unmet need
- No clear commercialization strategy
- Limited understanding of end-users
- Missing market size analysis
- Weak business model
- Not showing novelty or IP potential
- Lack of evidence for technical readiness
- Unclear use of grant funds
- Weak explanation of team capacity
FAQ
1. What is the C-CAMP Wadhwani Innovation Network Centre of Excellence grant?
It is a funding opportunity that supports Indian start-ups and academic innovators working on biotech and bioengineering technologies with commercial potential.
2. What is the maximum grant amount?
Selected applicants may receive grants of up to ₹1 crore.
3. Who can apply?
Indian start-ups and academic innovators working on translation-based technologies or commercially relevant innovations can apply.
4. What sectors are supported?
The programme supports Healthcare, Drugs, Medical Devices, Diagnostics, Industrial Biotechnology, Agriculture, MedTech, and related biotech and bioengineering fields.
5. What stage should the technology be at?
The technology should be beyond TRL4. This means it should have moved beyond early research and should be ready for validation, pilot testing, prototype refinement, or scale-up.
6. What kind of projects can receive support?
Projects involving pilot studies, validation studies, prototype refinement, scale-up activities, additional data generation, and preparation for next-level funding may receive support.
7. What are the main selection criteria?
Selection is based on product orientation, novelty, IP potential, unmet need, team strength, business model, commercialization strategy, end-user understanding, and market size.
Conclusion
The C-CAMP Wadhwani Innovation Network Centre of Excellence provides important support for Indian biotech and bioengineering start-ups and academic innovators ready to move from lab-stage development toward market-ready solutions. With grants of up to ₹1 crore, the programme helps advance technologies beyond TRL4 through validation, prototype refinement, scaling, and commercialization support. Applicants should present a clear, product-focused, technically validated, and commercially viable innovation with strong market relevance and a capable team.
For more information, visit Centre for Cellular and Molecular Platforms.